2010 Cannabinoids CBD Clinical Trials 
Project CBD
MARCH 21, 2023
For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy.
CannaMD
AUGUST 8, 2020
In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. So sit back, relax – and if you can’t relax, grab some CBD! What is CBD? Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
MAY 13, 2022
There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. When shopping for a strain for chronic pain, look for one that matches the cannabinoid and terpene profile, not one that matches the strain name exactly. CBD also has properties and may assist with pain relief. The chemovar.
Greencamp
AUGUST 16, 2018
Exploring the available research on ALS and cannabinoids. The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. The first study I will reference is from 2006, conducted on mice.
Healer
MARCH 26, 2021
Since 2015, the National Institutes of Health’s National Institute on Drug Abuse has funded research surrounding the therapeutic benefits of tetrahydrocannabinol (THC) and cannabidiol (CBD) for the treatment of pain as an alternative to opioids, addiction and other disorders. WHAT ABOUT CBD? Gregory Rec/Staff Photographer.
SpeedWeed
MARCH 18, 2021
Another group received an 11% CBD product with minimal THC. A third group received a balanced THC-CBD product, with roughly 8% THC and 8% CBD. A fourth group received a placebo with almost zero active cannabinoids. for the production of cannabis used in federally-regulated clinical trials. Bruce Kennedy.
Otherside Farms
JANUARY 23, 2019
Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.
Expert insights. Personalized for you.
144 
Let's personalize your content